Literature DB >> 20638335

Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.

Chui-Yee Fong1, Arjunan Subramanian, Arijit Biswas, Kalamegam Gauthaman, Prarthana Srikanth, Manoor Prakash Hande, Ariff Bongso.   

Abstract

Human mesenchymal stem cells (MSC) are non-controversial multipotent stem cells. Their presence in umbilical cord blood (UCB) has been debated in some studies and others report low counts per cord blood unit and poor proliferation rates. On the other hand, Wharton's jelly of human umbilical cords appears to be a rich source of human MSC. This study derived 13 human Wharton's jelly stem cell (WJSC) lines from 13 human umbilical cords (100%) and recovered 4.7 +/- 0.2 x 10(6) live WJSC/cm of cord before culture. Complex culture medium produced greater proliferation rates of the WJSC in culture compared with simple medium. The mean population doubling times were 24.47 +/- 0.33 to 26.25 +/- 0.50 h in complex medium. The stem-cell markers of the WJSC were retained for at least 10 passages in both media. After programmed machine freezing, the thaw-survival rates of WJSC were 85-90% and they could be differentiated into neurons. Given the high derivation efficiency, availability of large numbers of fresh live cells, high expansion capabilities, prolonged maintenance of stem-cell properties and differentiation potential, it is proposed that human WJSC may be frozen at the same time as UCB in cord blood banks for regenerative medicine purposes.
Copyright © 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638335     DOI: 10.1016/j.rbmo.2010.04.010

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  36 in total

1.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 2.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

3.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

Review 4.  Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues.

Authors:  Fatemeh Hendijani
Journal:  Cell Prolif       Date:  2017-02-01       Impact factor: 6.831

Review 5.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

6.  Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.

Authors:  Hao Daniel Lin; Ariff Bongso; Kalamegam Gauthaman; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

7.  Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment.

Authors:  Chui-Yee Fong; Arjunan Subramanian; Kalamegam Gauthaman; Jayarama Venugopal; Arijit Biswas; Seeram Ramakrishna; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

8.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.

Authors:  Maria Carmen Arufe; Alexandre De la Fuente; Isaac Fuentes; Francisco Javier De Toro; Francisco Javier Blanco
Journal:  World J Orthop       Date:  2011-06-18

9.  Cryopreservation effects on Wharton's Jelly Stem Cells proteome.

Authors:  F Di Giuseppe; L Pierdomenico; E Eleuterio; M Sulpizio; P Lanuti; A Riviello; G Bologna; M Gesi; C Di Ilio; S Miscia; M Marchisio; S Angelucci
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

10.  ACSL1 Is Associated With Fetal Programming of Insulin Sensitivity and Cellular Lipid Content.

Authors:  Roy Joseph; Jeremie Poschmann; Rami Sukarieh; Peh Gek Too; Sofi G Julien; Feng Xu; Ai Ling Teh; Joanna D Holbrook; Kai Lyn Ng; Yap Seng Chong; Peter D Gluckman; Shyam Prabhakar; Walter Stünkel
Journal:  Mol Endocrinol       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.